5.15% people developed anti-bodies for Covid-19 in Bhubaneswar

Bhubaneswar: Antibodies against the COVID-19 infection were found in 5.15 per cent of people in the second phase sero-prevalence survey conducted across 25 wards in Bhubaneswar.

The low prevalence of antibody in the community serological study by Regional Medical Research Centre (RMRC) indicates that the state capital could be ‘one of the protected cities’ with respect to the COVID-19 virulence across the country.

Bhubaneswar Municipal Corporation (BMC) Commissioner Prem Chandra Chaudhary said, “The less prevalence of the antibody in the city population indicates that still there is a high risk of infection in near future and thus the city is currently experiencing a spike in the COVID-19 positive cases.”

However, the BMC Commissioner urged the citizens to continue adherence to the COVID-19 Protocol of wearing masks appropriately, keeping a minimum of 2 metre social distancing norms in public places and strict no to crowding so that we would keep Corona at bay.

It can be mentioned here that during the two-day-long community serological study by RMRC on August 28 and 29, the city-based research institute of ICMR received 1,320 samples from various locations from where the Phase I samples were collected earlier.

Unlike other three types of tests conducted across the city to know the positive or negative status of an affected individual due to COVID-19, this serological surveillance test provides insights into the community exposure levels which were found very low even during the first phase with 1.42%.

In fact, technically, after 28 days of the first serological surveillance, the second one is to be conducted as per the ICMR guidelines.